Kerith E. Spicknall
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kerith E. Spicknall has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Diya F. Mutasim
Department of Dermatology, University of Cincinnati, Cincinnati, OH, USA
3 shared publicationsAdaeze Egesi
Department of Dermatology, University of Cincinnati, Cincinnati, OH, USA
1 shared publicationLauren E. Dubas
University of Cincinnati Department of Dermatology 231 Albert Sabin Way, ML#0592 Cincinnati OH 45267‐0592
1 shared publication
Latest Publications
- 1 March 2018
- Published by Frontline Medical Communications, Inc. in Seminars in Cutaneous Medicine and Surgery
- Vol. 37 (1) , 18-23
Sézary syndrome—clinical and histopathologic features, differential diagnosis, and treatment
Sézary syndrome (SS) is a rare subtype of cutaneous T-cell lymphoma marked by erythroderma, circulating neoplastic T cells, and poor prognosis. Its low incidence has made the study of its etiology, immunologic/molecular pathways, and effective treatments difficult. Because histopathology may be nonspecific in SS, microscopic findings must be correlated with the clinical presentation and the results of blood evaluation in order to make the diagnosis. Treatments that preserve, rather than compromise, the immune system are preferred.
- 1 March 2018
- Published by Frontline Medical Communications, Inc. in Seminars in Cutaneous Medicine and Surgery
- Vol. 37 (1) , 18-23
Sézary syndrome—clinical and histopathologic features, differential diagnosis, and treatment
Sézary syndrome (SS) is a rare subtype of cutaneous T-cell lymphoma marked by erythroderma, circulating neoplastic T cells, and poor prognosis. Its low incidence has made the study of its etiology, immunologic/molecular pathways, and effective treatments difficult. Because histopathology may be nonspecific in SS, microscopic findings must be correlated with the clinical presentation and the results of blood evaluation in order to make the diagnosis. Treatments that preserve, rather than compromise, the immune system are preferred.
- 13 June 2016
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 43 (9) , 781-786
Wong‐type dermatomyositis: a mimic of many dermatoses
Wong‐type dermatomyositis (DM) is a rare variant characterized by keratotic follicular papules that may mimic pityriasis rubra pilaris. Histopathologic examination shows follicular and non‐follicular epidermal invaginations filled with keratin. The diagnosis is often delayed. Twenty‐four cases of Wong‐type DM have been reported thus far in the literature. Herein, we report the clinical and histopathologic findings of three additional cases in order to raise awareness of the disorder.
- 13 June 2016
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 43 (9) , 781-786
Wong‐type dermatomyositis: a mimic of many dermatoses
Wong‐type dermatomyositis (DM) is a rare variant characterized by keratotic follicular papules that may mimic pityriasis rubra pilaris. Histopathologic examination shows follicular and non‐follicular epidermal invaginations filled with keratin. The diagnosis is often delayed. Twenty‐four cases of Wong‐type DM have been reported thus far in the literature. Herein, we report the clinical and histopathologic findings of three additional cases in order to raise awareness of the disorder.
- 11 April 2013
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 40 (5) , 442-444
Cutaneous macroglobulinosis with monotypic plasma cells: A specific manifestation of Waldenström macroglobulinemia
- 11 April 2013
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 40 (5) , 442-444
Cutaneous macroglobulinosis with monotypic plasma cells: A specific manifestation of Waldenström macroglobulinemia
- 3 March 2013
- Published by Wiley in International Journal of Dermatology
- Vol. 53 (1) , e3-e5
Localized toxic erythema of chemotherapy during treatment with paclitaxel
- 3 March 2013
- Published by Wiley in International Journal of Dermatology
- Vol. 53 (1) , e3-e5
Localized toxic erythema of chemotherapy during treatment with paclitaxel